Medicon Valley Alliance would like to congratulate, Roche Pharmaceuticals, with the prestigious “Best Place to work-award” awarded by the organisation, Great Place to Work last week. Roche Pharmaceuticals, which was the only life science company among the winners, was awarded
Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.
MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.
If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.
These are some of the conclusion in the 2019 edition of the “State of Medicon Valley analysis” published today and presented at the Medicon Valley Alliance Annual Meeting this afternoon. The analysis, which can be downloaded free of charge here,
The upcoming national Swedish life science strategy must take the Medicon Valley region´s potential for growth and collaboration into account, according to MVA CEO, Petter Hartman, and chairman of regional development, Region Skåne, Anna Jähnke (M). Read full column
In the recently published edition of Copenhagen Post Medicon Valley Alliance chairman, Søren Bregenholt, highlights the unique window of opportunity to strengthen the coordination and collaboration between the Danish and Swedish national life science strategies. (See page 13 here) The
The need for national funding for cross-border life science initiatives was among the topics discussed at last week´s high-level seminar in the Swedish Parliament, Riksdagen, organized by Medicon Valley Alliance and Region Skåne, and hosted by MP´s Rikard Larsson (S)
In the recently published Labiotech-ranking of European Biotech Incubators, COBIS, makes the list as the only Danish and Medicon Valley based incubator. There are, however, two Swedish incubators on the list, which also includes AstraZeneca BioVentureHub in Mölndal and Umeå
The recently published State of the Øresund region analysis covers a broad range of highly relevant issues including infra-structure and traffic, cultural collaboration and health care and life science. As part of the latter, MVA CEO, Petter Hartman is interviewed
“Sweden has strong innovation environments and a tradition of commercialisation. Denmark has large investors in pharmaceuticals as well as capital-rich private foundations. This creates exciting dynamics and makes us more competitive”, says MVA CEO Petter Hartman in a recently published
The Danish-Swedish ReproUnion collaboration continues to make a positive difference to patients, researchers and everybody else interested in the way fertility/infertility affects us as individuals and society as a whole. From a patient perspective the infertility counselling initiative located at